MedTrace Logo

Cognitive Side Effects of Commonly Prescribed Medications in Pediatric Migraine

NCT00777218 · Status: WITHDRAWN · Phase: NA · Type: INTERVENTIONAL

Last updated 2020-12-17

No results posted yet for this study

Summary

The purpose of this study is to determine if there are significant differences in the side effects related to memory, repetition and recall among these three drugs when used in a pediatric population.

Conditions

Interventions

DRUG

propranolol

standard pediatric doses, based on body weight

DRUG

zonisamide

standard pediatric dosages, based on body weight

DRUG

topiramate

standard pediatric dosages, based on body weight

Sponsors & Collaborators

  • University of South Alabama

    lead OTHER

Principal Investigators

  • J. I. Lopez, MD · University of South Alabama Department of Neurology

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
8 Years
Max Age
17 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-08-31
Primary Completion
2010-12-31
Completion
2011-07-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00777218 on ClinicalTrials.gov